Integrated Filing — IndAS



General information about company

Scrip Code 524091
NSE Symbol CARYSIL
MSEI Symbol NA
ISIN INE482D01024
Name of company CARYSIL LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 20-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 11-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacturing of Kitchen and Bath Products
Start date and time of board meeting 20-05-2026   12:45:00
End date and time of board meeting 20-05-2026   14:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 19-05-2025
Indicate Company website link for updated RPT policy of the Company www.carysil.com
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? Yes
No. of times funds raised during the quarter 1
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NA



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 12,578.00 50,462.00
Other income 525.00 1,725.00
Total income 13,103.00 52,187.00
2 Expenses
(a) Cost of materials consumed 4,662.00 19,083.00
(b) Purchases of stock-in-trade 1,017.00 3,296.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (311.00) (364.00)
(d) Employee benefit expense 1,276.00 4,668.00
(e) Finance costs 251.00 1,037.00
(f) Depreciation, depletion and amortisation expense 792.00 2,906.00
(f) Other Expenses
1 Other expenses 3,297.00 12,940.00
Total other expenses 3,297.00 12,940.00
Total expenses 10,984.00 43,566.00
3 Total profit before exceptional items and tax 2,119.00 8,621.00
4 Exceptional items 0.00 (104.00)
5 Total profit before tax 2,119.00 8,517.00
6 Tax expense
7 Current tax 525.00 2,266.00
8 Deferred tax (24.00) (117.00)
9 Total tax expenses 501.00 2,149.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,618.00 6,368.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,618.00 6,368.00
17 Other comprehensive income net of taxes 36.00 57.00
18 Total Comprehensive Income for the period 1,654.00 6,425.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 569.00 569.00
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 0.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 5.69 22.39
Diluted earnings (loss) per share from continuing operations 5.69 22.39
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 5.69 22.39
Diluted earnings (loss) per share from continuing and discontinued operations 5.69 22.39
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) NOTES 1. The Audited Standalone and Consolidated financial results of the company for the quarter & year ended March 31, 2026 were reviewed by the Audit committee and approved by the Board of Directors in their respective meetings held on May 20, 2026. The Statutory Auditors have carried out Statutory Audit of the same and expressed an unmodified audit report on these financial results. 2. Exceptional Items: Effective 21 November 2025, the Government of India has consolidated multiple existing labour legislation into a unified framework comprising four Labour Codes (collectively referred to as the 'New Labour Codes'). These legislative changes have revised the definition of wages for the purpose of computation of employee benefits and expanded the scope and eligibility of certain employees related social security benefits. Based on a detailed assessment carried out, the parent company and its subsidiaries incorporated in India have evaluated the incremental impact arising from the implementation of the New Labour Codes. Considering the materiality, regulatory-driven and non-recurring nature of this impact, an incremental impact of Rs. 1.04 crores and of Rs. 1.13 crores have been recognized as an exceptional item in standalone and consolidated financial results respectively. 3. The Statement has been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under section 133 of the Companies Act, 2013 read with rule 3 of the Companies (Indian Accounting Standard) Rules, 2015 and other relevant provisions of the Act. 4. The Board of Directors have recommended a dividend of Rs. 3/- per equity share (face value of Rs. 2 each) for the year ended 31 March 2026, subject to necessary approval by the members in the ensuing Annual General Meeting of the Company. 5. The figures for the quarter ended 31 March represent the balancing figures between audited figures in respect of the full financial year and those published till the third quarter of the respective financial year, which were subjected to limited review by statutory auditors. 6. The Company has single reportable segment namely Kitchen & Bath Products for the purpose of Ind AS on segment reporting. 7. The previous period figures have been regrouped/ reclassified, wherever necessary, to correspond with those of the current period. However, the impact of the same is not material to the financial results.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 21,015.00
Capital work-in-progress 2,436.00
Investment property 2,989.00
Goodwill 0.00
Other intangible assets 228.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method 858.00
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current
Loans, non-current 7,383.00
Other non-current financial assets
1 Other non-current financial assets 320.00
Total of other non-current financial assets 320.00
Total non-current financial assets 7,703.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 359.00
Total of other non-current assets 359.00
Total non-current assets 35,588.00
2 Current assets
Inventories 11,874.00
Current financial asset
Current investments 0.00
Trade receivables, current 9,686.00
Cash and cash equivalents 126.00
Bank balance other than cash and cash equivalents 4,470.00
Loans, current 521.00
Other current financial assets
Total of other current financial assets 459.00
Total current financial assets 15,262.00
Current tax assets (net) 55.00
Other current assets
1 Other current assets 2,223.00
Total of other current assets 2,223.00
Total current assets 29,414.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 65,002.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 569.00
Other equity 46,081.00
Total equity attributable to owners of parent 46,650.00
Non controlling interest
Total equity 46,650.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 880.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Other non-current financial liabilities 813.00
Total of other non-current financial liabilities 813.00
Total non-current financial liabilities 1,693.00
Provisions, non-current 0.00
Deferred tax liabilities (net) 366.00
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 2,059.00
Current liabilities
Current financial liabilities
Borrowings, current 10,406.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 4,290.00
Total Trade payable 4,290.00
Other current financial liabilities
1 Other current financial liabilities 1,071.00
Total of other current financial liabilities 1,071.00
Total current financial liabilities 15,767.00
Other current liabilities 423.00
1 Other current liabilities 423.00
Total of other current liabilities 423.00
Provisions, current 0.00
Current tax liabilities (Net) 103.00
Deferred government grants, Current
Total current liabilities 16,293.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 18,352.00
Total equity and liabilites 65,002.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of defined benefit plans (net of taxes) 48.00 76.00
Total Amount of items that will not be reclassified to profit and loss 48.00 76.00
2 Income tax relating to items that will not be reclassified to profit or loss 12.00 19.00
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss
5 Total Other comprehensive income 36.00 57.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 8,517.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,037.00
Adjustments for decrease (increase) in inventories (1,114.00)
Adjustments for decrease (increase) in trade receivables, current (592.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 106.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 741.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 89.00
Adjustments for depreciation and amortisation expense 2,906.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 77.00
Adjustments for provisions, current 124.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 942.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (7.00)
Adjustments for undistributed profits of associates (5.00)
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 2,430.00
Net cash flows from (used in) operations 10,947.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,249.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 8,698.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 16.00
Purchase of property, plant and equipment 5,159.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 2,347.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 850.00
Cash advances and loans made to other parties 2,785.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 942.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) investing activities (5,489.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 16.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings (1,132.00)
Repayments of borrowings 0.00
Payments of lease liabilities 378.00
Dividends paid 686.00
Interest paid 1,046.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (3,226.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (17.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (17.00)
Cash and cash equivalents cash flow statement at beginning of period 143.00
Cash and cash equivalents cash flow statement at end of period 126.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 PARK & Co. Yes 31-05-2028


Statement on Deviation or Variation for proceeds of Public Issue, Rights Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)

Amount in (Lakhs)

Mode of Fund Raising QIP
Description of mode of fund raising (Applicable in case of others is selected)
Date of Raising Funds 04-07-2024
Amount Raised 12,500.00
Report filed for Quarter ended 31-03-2026
Monitoring Agency Applicable
Monitoring Agency Name, if applicable ICRA Limited
Is there a Deviation / Variation in use of funds raised No
If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders
If Yes, Date of shareholder Approval
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review No Comments
Comments of the auditors, if any No Comments
Sr. Original Object Modified Object, if any Original Allocation Modified allocation, if any Funds Utilised Amount of Deviation/Variation for the quarter according to applicable object Remarks if any
1 Funding the capital expenditure towards procurement and installation of machinery, equipment and moulds required for the Company’s existing and/or new manufacturing facilities NIL 6,250.00 0.00 2,871.00 0.00
2 Funding the Company’s working capital requirements NIL 3,125.00 0.00 3,125.00 0.00
3 General corporate purposes NIL 2,790.00 0.00 2,790.00 0.00


Signatory Details

Name of signatory Anand Sharma
Designation of person Chief Financial Officer
Place Mumbai
Date 20-05-2026




Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Carysil Limited Acrycol Minerals Limited Enterprises owned or significantly influenced by KMP or their relative Purchase of goods or services 3,600.00 Transactions are at arm's length basis 2,505.00 0.00 0.00
2 Carysil Limited Carysilnox Limited Subsidiary Company Purchase of goods or services 600.00 Transactions are at arm's length basis 327.00 0.00 0.00
3 Carysil Limited Carysilnox Limited Subsidiary Company Purchase of goods or services 200.00 Transactions are at arm's length basis 109.00 0.00 0.00
4 Carysil Limited Carysilnox Limited Subsidiary Company Sale of goods or services 300.00 Transactions are at arm's length basis 147.00 0.00 0.00
5 Carysil Limited Carysilnox Limited Subsidiary Company Any other transaction Royalty received 16.00 Transactions are at arm's length basis 11.00 0.00 0.00
6 Carysil Limited Carysilnox Limited Subsidiary Company Any other transaction Rent received 1.00 Transactions are at arm's length basis 1.00 0.00 0.00
7 Carysil Limited Carysilnox Limited Subsidiary Company Any other transaction Guarantee Commisision received 16.00 Transactions are at arm's length basis 13.00 0.00 0.00
8 Carysil Limited Carysilnox Limited Subsidiary Company Any other transaction Reimbursement / sharing of SAP software expenses 35.00 Transactions are at arm's length basis 24.00 0.00 0.00
9 Carysil Limited Veritas Legal Independent Director of the Company, holds 6.5% of partnership firm Any other transaction Availing legal services 20.00 Transactions are at arm's length basis 9.00 0.00 0.00
10 Carysil Limited Ashwanila Charitable Trust Enterprises owned or significantly influenced by KMP or their relatives Any other transaction CSR and Donation Activity 105.00 Transactions are at arm's length basis 84.00 0.00 0.00
11 Carysil Limited Ashwanila Charitable Trust Enterprises owned or significantly influenced by KMP or their relatives Any other transaction Rent received 2.00 Transactions are at arm's length basis 2.00 0.00 0.00
12 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Sale of goods or services Transactions are at arm's length basis 212.00 18.00 (101.00)
13 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Interest received Transactions are at arm's length basis 40.00 0.00 0.00
14 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Any other transaction Royalty Paid Transactions are at arm's length basis 2.00 0.00 0.00
15 Carysil Limited Carysil Products Limited Step down Subsidiary of WOS Sale of goods or services Transactions are at arm's length basis 4,642.00 935.00 1,233.00
16 Carysil Limited Carysil Online Limited Wholly Owned Subsidiary Sale of goods or services Transactions are at arm's length basis 273.00 0.00 0.00
17 Carysil Limited Chirag Parekh Chairman & Managing Director (KMP) Any other transaction Remuneration Transactions are at arm's length basis 677.00 0.00 0.00
18 Carysil Limited Rhea Parekh Place of Profit Any other transaction Remuneration 50.00 Transactions are at arm's length basis 50.00 0.00 0.00
19 Carysil Limited Carysil FZ LLC Wholly Owned Subsidiary Interest received Transactions are at arm's length basis 54.00 0.00 0.00
20 Carysil Limited Carysil FZ LLC Wholly Owned Subsidiary Any other transaction Guarantee Commission received Transactions are at arm's length basis 3.00 0.00 0.00
21 Carysil Limited Carysil USA Inc. Wholly Owned Subsidiary Loan Transactions are at arm's length basis 1,736.00 0.00 0.00
22 Carysil Limited Carysil USA Inc. Wholly Owned Subsidiary Interest received Transactions are at arm's length basis 524.00 0.00 0.00
23 Carysil Limited Carysil UK Limited Wholly Owned Subsidiary Any other transaction Guarantee Commision received Transactions are at arm's length basis 17.00 0.00 0.00
24 Carysil Limited Carysil Products Limited Step down Subsidiary of WOS Any other transaction Sale of goods or services Transactions are at arm's length basis 4,642.00 0.00 0.00
25 Carysil Limited Carysil Products Limited Step down Subsidiary of WOS Any other transaction Commission Paid Transactions are at arm's length basis 282.00 0.00 0.00
26 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Any other transaction Commission paid Transactions are at arm's length basis 157.00 0.00 0.00
27 Carysilnox Limited (Formerly known as Carysil Steel Ltd) Carysil Gmbh, Germay Fellow Subsidiary Sale of goods or services Transactions are at arm's length basis 8.00 12.00 (2.00)
28 Carysilnox Limited (Formerly known as Carysil Steel Ltd) Carysil Products Limited Fellow Subsidiary Sale of goods or services Transactions are at arm's length basis 461.00 85.00 307.00
29 Carysilnox Limited (Formerly known as Carysil Steel Ltd) Carysil Online Limited Fellow Subsidiary Sale of goods or services Transactions are at arm's length basis 28.00 0.00 0.00
30 Carysilnox Limited (Formerly known as Carysil Steel Ltd) Carysil Gmbh, Germay Fellow Subsidiary Any other transaction Commission Paid on sale Transactions are at arm's length basis 90.00 0.00 0.00
31 Carysil Limited Carysil Gmbh, Germay Wholly Owned Subsidiary Any other transaction Guarantee Commission received Transactions are at arm's length basis 0.00 0.00 0.00
32 Carysil Limited Carysil USA Inc. Wholly Owned Subsidiary Any other transaction Guarantee Commission received Transactions are at arm's length basis 16.00 0.00 0.00
33 Carysil Limited Carysil Ankastre Sistemleri Ticaret Limited Sirketi Wholly Owned Subsidiary Sale of goods or services Transactions are at arm's length basis 0.00 0.00 0.00
34 Carysil Limited Carysil USA Inc. Wholly Owned Subsidiary Sale of goods or services Transactions are at arm's length basis 0.00 0.00 0.00
35 Carysil Limited Carysil FZ LLC Wholly Owned Subsidiary Loan Transactions are at arm's length basis 0.00 0.00 0.00
36 Carysil Limited Carysil FZ LLC Wholly Owned Subsidiary Any other transaction Guarantee Given Transactions are at arm's length basis 3.00 0.00 0.00
37 Carysil Limited Carysil USA Inc. Wholly Owned Subsidiary Any other transaction Guarantee Given Transactions are at arm's length basis 16.00 0.00 0.00
38 Carysil Limited Carysil FZ LLC Wholly Owned Subsidiary Any other transaction Royalty Received Transactions are at arm's length basis 13.00 0.00 0.00
39 Carysil Limited United Granite LLC Wholly Owned Subsidiary Any other transaction Guarantee Commision received Transactions are at arm's length basis 2.00 0.00 0.00
40 Carysil Limited Carysil Online Limited Wholly Owned Subsidiary Any other transaction Reimbursement of expenses Transactions are at arm's length basis 8.00 0.00 0.00
41 Carysil Limited Carysil Ankastre Sistemleri Ticaret Limited Wholly Owned Subsidiary Any other transaction Sundry balances written off Transactions are at arm's length basis 81.00 0.00 0.00
42 Carysil Limited Carysil Products Limited Step down Subsidiary of WOS Any other transaction Trade Receivables Transactions are at arm's length basis 1,233.00 0.00 0.00
Total value of transaction during the reporting period 18,502.00